Rockwell Medical Q1 record sales $22.7M (+15% YoY); raises 2024 guidance across all metrics

ROCKWELL MEDICAL, INC.

2024-Q1 EPS reported -$0.06 revenue$22,676,000

Q1 net sales $22.7M (record), up 15% YoY; ex-deferred revenue, up 25%. Gross profit $3.1M (+18% YoY).
Net loss improved to $1.7M from $1.8M YoY; adjusted EBITDA ($0.5M) vs ($1.0M).
Raised FY2024 guidance: net sales $90-94M (prev $84-88M); gross profit $13-15M; adjusted EBITDA $0.5-1.0M.
Amended Innovatus loan: rate reduced, maturity extended to Jan 2029; interest-only through Sep 2026.
New distribution deals with BioNuclear and AMI expected ~$1M annual revenue; new supply agreement with large Mountain West health system.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ROCKWELL MEDICAL, INC. reported three months ended March 31, 2024 results: revenue $22.7 million, net income Net loss of $1.7 million, EPS $(0.06). Guidance raised.

Period: three months ended March 31, 2024
Revenue: $22.7 million
Net income: Net loss of $1.7 million
EPS: $(0.06)
Guidance: raised
Result: reported results

Exact text from the filing

by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance • Reports record net sales of $22.7 million for the first quarter of 2024, an increase of 25% over net product sales and a 15% increase over net sales for the same period in 2023. • Reports record gross profit of $3.1

View on SEC.gov

1362 earnings releases filed in the last 30 days. Browse all earnings releases →

ROCKWELL MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001628280-24-023035

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.